Your Health Matters


Medicare is looking to see if they should provide coverage for the new Alzheimer's drug

Alzheimer Drug
Posted at 6:42 AM, Jul 14, 2021
and last updated 2021-07-14 09:43:03-04

BAKERSFIELD, Calif. (KERO) — Medicare is currently looking at whether is should cover the new Alzheimer's drug, aduhelm.

The drug comes with a $56,000 yearly price tag. It's also been criticized for not having enough evidence showing that it is beneficial to Alzheimer's patients.

A final decision on coverage isn't expected until spring of next year, but an initial ruling could happen before then.